A new market analysis highlights the steady growth trajectory of the global vascular stent market. Valued at USD 11.39 billion in 2024 and projected to grow from USD 12.00 billion in 2025 to a substantial USD 18.18 billion by 2032, the market is set to exhibit a Compound Annual Growth Rate (CAGR) of 6.12% during the forecast period. This consistent expansion is primarily fueled by the increasing global prevalence of cardiovascular diseases, ongoing advancements in stent technology, and a rising preference for minimally invasive surgical procedures.
Read Complete Report Details: https://www.kingsresearch.com/vascular-stent-market-2110
Report Highlights
The comprehensive report analyzes the global vascular stent market, segmenting it by Product (Coronary Stents, Peripheral Stents, Endovascular Aortic Repair (EVAR) Stent Grafts), by Technology (Drug-eluting Stents (DES), Bare-metal Stents (BMS), Bioresorbable Stents, Covered Stents, and Others), by Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), by End-User (Hospitals & Cardiac Centers, Ambulatory Surgical Centers, and Others), and Regional Analysis. This detailed segmentation provides valuable insights into the market's dynamics and emerging trends.
Key Market Drivers
- Increasing Prevalence of Cardiovascular Diseases (CVDs): The global rise in chronic conditions such as coronary artery disease (CAD), peripheral artery disease (PAD), and aneurysms, driven by aging populations, sedentary lifestyles, obesity, and diabetes, is the primary factor escalating the demand for vascular stents. These conditions often lead to arterial blockages and narrowing, necessitating stent implantation.
- Technological Advancements in Stent Design and Materials: Continuous innovation in stent technology, including the development of advanced drug-eluting stents (DES) with improved drug delivery mechanisms, thinner struts, and more biocompatible polymers, is significantly enhancing treatment outcomes by reducing restenosis rates and improving long-term patency. The emergence of bioresorbable stents also contributes to market growth.
- Growing Preference for Minimally Invasive Procedures: Patients and healthcare providers increasingly prefer minimally invasive procedures like angioplasty and stenting over traditional open surgeries. These procedures offer advantages such as shorter hospital stays, reduced pain, quicker recovery times, and lower complication rates, making them a more attractive treatment option.
- Rising Adoption of Angioplasty Procedures: The increasing number of angioplasty procedures performed globally, particularly percutaneous coronary interventions (PCIs) and peripheral interventions, directly drives the demand for vascular stents as they are often an integral part of these revascularization strategies.
- Favorable Reimbursement Policies and Awareness Programs: Supportive reimbursement policies in developed economies and increasing patient awareness regarding the benefits of minimally invasive interventions are contributing to broader adoption and market expansion.
- This report offers a strategic overview of the global vascular stent market, providing valuable insights for stent manufacturers, medical device companies, healthcare providers, research institutions, and investors seeking to capitalize on the evolving landscape of cardiovascular and peripheral interventions.
About Kings Research
Kings Research is a leading market research and consulting firm that provides comprehensive market intelligence and strategic insights to businesses across various industries.
Comments
0 comment